Fulgent Genetics Inc (FLGT) stock news · rev $322.7M
Fulgent Genetics Inc (FLGT) is a diagnostics & research company listed on US.
This FLGT news page leads with what Fulgent Genetics Inc filed — not a scraped headline mill.
No cached 8-K sentence for FLGT yet. We will not pad this page with generic market recap.
Latest reported FLGT revenue for 2025-12-31 was $322.7M. Net income was -$60.5M. Revenue was up 13.8% from 2024-12-31 to 2025-12-31. FLGT currently screens at market cap $586.6M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the FLGT stock page; for the tape open the quote page.
FLGT stock news FAQ
What are FLGT's latest revenue and net income?
Latest cached Fulgent Genetics Inc (FLGT) revenue for Dec 31, 2025 was $322.7M. Net income was -$60.5M. Statements: https://lician.com/financials/flgt
How did FLGT revenue change from the prior cached period?
Cached Fulgent Genetics Inc (FLGT) revenue was up 13.8% from $283.5M (Dec 31, 2024) to $322.7M (Dec 31, 2025). Statements: https://lician.com/financials/flgt
What is FLGT's market cap?
Fulgent Genetics Inc (FLGT) market cap is $586.6M on the latest cached fundamentals snapshot.
What kind of company is FLGT?
Fulgent Genetics Inc (FLGT) is a diagnostics & research company listed on US.
Where is FLGT stock news listed?
Cached stock news for Fulgent Genetics Inc (FLGT) is listed at https://lician.com/news/flgt. Filings: https://lician.com/sec/flgt
Not investment advice.